CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid

Negative
AI Analysis

Summary

Aurora Cannabis maintains a recommendation for shareholders to take no action regarding Curaleaf's hostile bid, pending Curaleaf's filing of a revised offer notice. Aurora's Special Committee will conduct a comprehensive review once the formal documentation is submitted.

Outcome Details

Hostile bid pending filing of Notice of Variation and Change; Special Committee to review once filed

Importance:7/10
Sentiment:
-0.30
M&Ahostile bidshareholder recommendationcannabisboard review
Related Companies

Read the original article

Published by PR Newswire Pharma on October 5, 2026 10:11 PM

Read Original